Sector
HealthcareOpen
₹1,165Prev. Close
₹1,157.8Turnover(Lac.)
₹3,641.6Day's High
₹1,183Day's Low
₹1,15352 Week's High
₹1,513.952 Week's Low
₹908Book Value
₹113.54Face Value
₹2Mkt Cap (₹ Cr.)
31,567.08P/E
81.7EPS
14.16Divi. Yield
0Y/e 31 Mar( In .Cr) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
---|---|---|---|---|
Equity Capital | 53.7 | 53.64 | 50.64 | 82.09 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 2,795.1 | 2,435.22 | 1,689.11 | 1,401.55 |
Net Worth | 2,848.8 | 2,488.86 | 1,739.75 | 1,483.64 |
Minority Interest |
No Record Found
No Record Found
No Record Found
Particulars (Rupees in Crores.) | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 | Mar-2020 |
---|---|---|---|---|---|
Gross Sales | 3,275.11 | 2,709.88 | 2,167.3 | 1,446.74 | 1,500.42 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 3,275.11 | 2,709.88 | 2,167.3 | 1,446.74 | 1,500.42 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 74.66 | 49.29 | 38.52 | 31.42 | 43.85 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
---|---|---|---|---|---|---|---|
Max Healthcare Institute Ltd MAXHEALTH | 1,096.15 | 135.56 | 1,06,482.48 | 231.3 | 0.14 | 686.11 | 81.72 |
Apollo Hospitals Enterprise Ltd APOLLOHOSP | 7,233.3 | 93.18 | 1,04,639.28 | 369.6 | 0.22 | 2,135.4 | 569.62 |
Fortis Healthcare Ltd FORTIS | 714.25 | 276.37 | 52,371.45 | 39.63 | 0.14 | 357.15 | 120.23 |
Syngene International Ltd SYNGENE | 919.7 | 85.1 | 37,373.55 | 96.6 | 0.13 | 821.3 | 107.27 |
Global Health Ltd MEDANTA | 1,175.3 | 81.7 | 31,071.53 | 104.47 | 0 | 664.61 | 113.49 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman & Managing Director
Naresh Kumar Trehan
Director & Group CEO
Pankaj Prakash Sahni
Independent Non Exe. Director
Hari S Bhartia
Independent Non Exe. Director
Praveen Mahajan
Independent Non Exe. Director
Rajan Bharti Mittal
Independent Non Exe. Director
RAVI GUPTA
Non Executive Director / Nominee
RAVI KANT JAIPURIA
Non Executive Director
SUNIL SACHDEVA
Non Executive Director / Nominee
Venkatesh Ratnasami
Independent Non Exe. Director
Vikram Singh Mehta
Company Sec. & Compli. Officer
Rahul Ranjan
Tel: -
Website: -
Email: -
Tel: -
Website: -
Email: -
Reports by Global Health Ltd
Summary
Global Health Limited was incorporated as Global Health Private Limited on August 13, 2004 at New Delhi, India as a Private Limited Company under the Companies Act, 1956. The Company converted into a Public Limited Company, passed by Shareholders at the EGM held on July 31, 2021 and consequently, name of the Company was changed to Global Health Limited dated August 11, 2021 issued by the RoC. The Company was founded by Dr. Naresh Trehan, a world-renowned cardiovascular and cardiothoracic surgeon. The Company is one of the largest private multi-speciality tertiary care providers operating in the North and East regions of India in terms of bed capacity with key specialties of cardiology and cardiac science, neurosciences, oncology, digestive and hepatobiliary sciences, orthopaedics, liver transplant, and kidney and urologoly. Under the Medanta brand, it has a network of 5 hospitals currently in operation including, Gurugram, Indore, Ranchi, Lucknow and Patna and one hospital in Noida, which is under construction. As at June 30, 2022, the Company provide healthcare services in over 30 medical specialties and is engaged over 1,300 doctors led by experienced department heads and, spanning an area of 4.7 million sq. ft., their operational hospitals have 2,467 installed beds to serve Indian and international patients.In November 2009, the Company opened its flagship hospital in Gurugram. In 2015, its subsidiary, Global Health Patliputra Private Limite (GHPPL), entered into a Conce
Read More
The Global Health Ltd shares price on NATIONAL STOCK EXCHANGE (NSE) is ₹1175.3 today.
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Global Health Ltd is ₹31567.08 Cr. as of 06 Dec ‘24
The PE and PB ratios of Global Health Ltd is 81.7 and 10.19 as of 06 Dec ‘24
The 52-week high/low is the highest and lowest price at which a Global Health Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Global Health Ltd is ₹908 and ₹1513.9 as of 06 Dec ‘24
Global Health Ltd's CAGR for 5 Years at N/I%, 3 Years at 40.74%, 1 Year at 15.38%, 6 Month at 3.15%, 3 Month at 1.29% and 1 Month at 9.06%.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
IIFL Securities Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
Invest wise with Expert advice